Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Tropisetron diminishes demyelination and disease severity in an animal model of multiple sclerosis.
T-bet is essential for Th1-mediated, but not Th17-mediated, CNS autoimmune disease.
Headaches in multiple sclerosis patients might imply an inflammatorial process.
Circulating dendritic cells of multiple sclerosis patients are proinflammatory and their frequency is correlated with MS-associated genetic risk factors.
Cutting-edge of advanced MRI for demyelinating diseases.
Experimental models of neuromyelitis optica.
Measurement of retinal nerve fiber layer thickness in eyes with optic disc swelling by using scanning laser polarimetry and optical coherence tomography.
Tumefactive multiple sclerosis and fingolimod: Immunotherapies and unintended consequences.
Requirement for safety monitoring for approved MS therapies - An overview.
[Targeted Therapy and Progressive Multifocal Leukoencephalopathy (PML): PML in the Era of Monoclonal Antibody Therapies].
New diagnostic criteria for multiple sclerosis in patients with clinically isolated syndromes: Some questions could be raised during clinical practice.
Vitamin d as a potential therapy in amyotrophic lateral sclerosis.
Anti-aquaporin 4 antibody-positive acute disseminated encephalomyelitis.
Is cervical decompression beneficial in patients with coexistent cervical stenosis and multiple sclerosis?
The role of pro- and anti-inflammatory cytokines in the pathogenesis of spontaneous canine CNS diseases.
"History had taken such a large piece out of my life" - Neuroscientist refugees from Hamburg during National Socialism.
A comparison of linear and nonlinear stability parameters in different clinical forms of multiple sclerosis.
Factors Related to Social Support in Neurological and Mental Disorders.
The role of neutralizing antibodies to interferon-β as a biomarker of persistent MRI activity in multiple sclerosis: a 7-year observational study.
Different definitions of neurodegeneration produce similar amyloid/neurodegeneration biomarker group findings.
Phosphodiesterase-5 inhibition promotes remyelination by MCP-1/CCR-2 and MMP-9 regulation in a cuprizone-induced demyelination model.
Development and validation of an ELISA for quantification of soluble IFN-β receptor: assessment in multiple sclerosis.
Dissecting the role of E2 protein domains on alphavirus pathogenicity.
Hereditary diffuse leukoencephalopathy with spheroids - a volumetric and radiological comparison with multiple sclerosis patients and healthy controls.
CD19 mRNA quantification improves rituximab treatment-to-target approach: A proof of concept study.
Pages
« first
‹ previous
…
646
647
648
649
650
651
652
653
654
…
next ›
last »